The facility will provide biopharmaceutical manufacturers with a shared, exploratory environment where they can collaborate with Merck scientists and engineers to solve their toughest challenges
Merck announced the expansion of its ‘M Lab Collaboration Center’ in Bengaluru. The expanded centre includes a simulated manufacturing environment and enables collaboration with Merck experts to evaluate processes and accelerates development and production of new therapies, the company said.
In addition, education on best practices and new approaches to develop, optimise and scale-up processes and ways to simplify global technology transfer will be available to customers, Merck said in a release here.
The facility will provide biopharmaceutical manufacturers with a shared, exploratory environment where they can closely collaborate with Merck scientists and engineers to solve their toughest challenges and accelerate development of new therapies, it said.
“Bengaluru is a hub for India’s rapidly growing biopharmaceutical manufacturing industry,” noted Udit Batra, Member of the Merck Executive Board and CEO, Life Science.
With the expansion of M Lab Collaboration Center in Bengaluru, customers are being provided with hands-on experience and customized support to optimise their manufacturing processes to quickly bring much-needed therapies to patients, he said.
The new M Lab Collaboration Center in Bengaluru is one of nine such centres around the world. At Merck, around 50,000 employees work to further develop technologies from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions, the release said.
- Advertisement -
Comments are closed.